Furthermore, Pin-EGFR-armed eNK cells are resistant to one of the most immunosuppressive factors of the GBM tumor microenvironment (TGF-β) while remaining viable and fully effective in the presence of the standard GBM chemotherapeutic drug (temozolomide). This evidence concerns the gene TGFB1 and neoplasm.